Ellen Snow - 15 Feb 2023 Form 4 Insider Report for Pear Therapeutics, Inc.

Reporting relationship
VP, Chief Accounting Officer
Issuer ticker
N/A
Reported as of
15 Feb 2023
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Feb 2023, 15:14:54 UTC
Prior SEC filing
24 Jan 2023
Next SEC filing
18 Jul 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stacie S. Aarestad, Attorney-in-Fact

Key filing fact

Ellen Snow filed Form 4 for Pear Therapeutics, Inc. on 17 Feb 2023.

Key facts

  • This page summarizes Ellen Snow's Form 4 filing for Pear Therapeutics, Inc..
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 17 Feb 2023, 15:14.

Change

  • Previous filing in this sequence was filed on 24 Jan 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PEARQ transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+199,864
Change %
Price
$0.000000
Shares after
199,864
Date
15 Feb 2023
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
199,864
Exercise price
Footnotes
F1, F2
PEARQ transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+40,000
Change %
Price
$0.000000
Shares after
40,000
Date
16 Feb 2023
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
40,000
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of PEAR Class A Common Stock.

Footnote F2

The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .